Polymorphism AGT2 (rs4762) is involved in the development of dermatologic events: Proof-of-concept in hepatocellular carcinoma patients treated with sorafenib.

World J Hepatol · 2022 · PMC9376774 · PMID 36158918

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

showed a trendP value = 0.06so close (0.05 < p ≤ 0.1)

By contrast, the AGT2 (rs4762) AA genotype was associated with a significant increased risk of eDAE with a HR = 4.43 (95%CI: 1.01-19.39; P value = 0.048; AA vs GG) in the univariate analysis, and showed a trend in the multivariate model with a HR = 4.24 (95%CI: 0.95-19.06]; P value = 0.06; AA vs GG), Table 5 .

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.